{"url_path":"/sec/gwll/10-k/2026/item-14","section_key":"item-14","section_title":"Item 14 PRINCIPAL ACCOUNTING FEES AND SERVICES**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1800373/0001477932-26-004130-index.html","accession_number":"0001477932-26-004130","cik":"0001800373","ticker":"GWLL","issuer_name":"GOLDENWELL BIOTECH, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1800373/0001477932-26-004130-index.html","primary_entity_key":"0001800373","primary_entity_name":"GOLDENWELL BIOTECH, INC."},"word_count":60,"has_tables":true,"body_markdown":"**ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES**\n\n \n\nFor the year ended December 31, 2025 and 2024, the total fees charged to the company for audit services, including quarterly reviews, were $27,000 and $30,500, respectively, for accounting services were $5,400 and $5,450, respectively, and for tax services and other services were $1,200 and $1,500, respectively \n\n \n\n \n\n26\n\n*Table of Contents*\n\n  \n\n**PART IV**"}